Blog

In this post, we'll explore the transition to paperless validation and the benefits it brings such as efficiency, cost reduction, and compliance assurance.

Learn how to simplify regulatory approval for post-approval changes and discover the benefits of implementing a PACM protocol and using a QRM platform.

Explore the essential role of CPV in your manufacturing process and discover the transformative impact of going digital in this blog post case study.

This post is the second installment of a two-part series on the incredible impact of generative AI, particularly ChatGPT, on validation in the life sciences.

This post is the first installment of a two-part series on the incredible impact of generative AI, particularly ChatGPT, on validation in the life sciences.

Discover how to leverage digital CPV to apply the ICH Q9 (R1) data-driven approaches and enable bias-free risk assessment in pharmaceutical manufacturing.

The post summarizes the key principles of CSA, various testing methodologies, risk management, and the benefits of digital software validation tools.

Discover how machine learning unlocks drug developability predictions' potential in a successful case study.

Unlocking the potential of Computer System Assurance (CSA) in pharmaceuticals: A roadmap for a seamless transition from CSV to CSA.

Blockchain technology is revolutionizing how data integrity is ensured in clinical trials, establishing a new level of trust and compliance.

In this post, we’ll look at 3 benefits of integrating process data with risk management and how it increases organizational efficiency and competitiveness.

How do we deliver objective evidence with a high degree of certainty it will withstand regulatory scrutiny? Technology tools like a VLMS hold the answer.

Learn about the requirements of the Annex 1 revision and how to ensure compliance with a digital risk management platform.

In this blog post, we will explore how making your transition from the traditional CSV to the new CSA approach can save you time and resources.

Sponsors and CROs are prioritizing digitization to build a foundation for decentralized clinical trials and using AI/ML tools to improve patient outcomes.